Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGb 761 in peripheral arterial disease
NCT00029991Phase 2Completed
- Sponsor
- National Center for Complementary and Integrative Health
- Start
- Sep 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ginkgo biloba extract in Peripheral Arterial Disease (PAD), intermittent claudication (IC), sponsored by National Center for Complementary and Integrative Health. Started Sep 2000; status: completed.
02
Drugs
ginkgo biloba extract
03
Conditions
Peripheral Arterial Disease (PAD)intermittent claudication (IC)
Beyond the preview
Go deeper on NCT00029991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00029991.